Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
about
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolutionPatients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis.Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission.Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoringUsefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter studyPractical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis
P2860
Q33667766-93C4394D-A821-40F8-B76D-7D6C4D94F1D4Q36114510-D9036588-6652-4BCE-BF6F-021EFF3A14B1Q36202746-75A5EF3F-8941-4F43-A659-C0B6F7682395Q37273489-FC06DB15-9814-4548-B9C2-B022D6E3D752Q39825139-646E29B2-0B9B-4F56-B029-7819D621036EQ42499487-2C569F32-7B1B-48A0-83DC-FF15804B23CBQ50205262-E5566ACF-8BAC-4D9E-913F-565DAFF24679Q50221428-78DB2E91-3D39-4A6F-B532-C14A7ED39E9DQ53171219-A272EDFF-B044-4224-8F47-FA00C280FCE0Q57284249-C54C6E58-0FE8-4C4B-BFB8-4B51B29D72F6Q57284254-23095DCD-6DBA-4BBE-9788-9F7A37603193Q57815098-1C0100A3-2458-4724-972C-B1070B6B984A
P2860
Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fecal calprotectin is a clinic ...... quiescent ulcerative colitis.
@en
type
label
Fecal calprotectin is a clinic ...... quiescent ulcerative colitis.
@en
prefLabel
Fecal calprotectin is a clinic ...... quiescent ulcerative colitis.
@en
P2093
P2860
P356
P1476
Fecal calprotectin is a clinic ...... quiescent ulcerative colitis.
@en
P2093
Hiroshi Takahashi
Hitoshi Yoshida
Katsuhito Arai
Katsuyuki Fukuda
Kunio Asonuma
Masayuki Saruta
Sayaka Yamaguchi
Yoshiaki Takeuchi
Yuichiro Kuroki
P2860
P356
10.1111/JGH.13061
P577
2015-07-25T00:00:00Z